CA
NZ
UK
AU
IND
US
Sanara MedTech Inc. (NASDAQ: SMTI) has finalized a significant merger agreement with MiMedx Group, Inc. whereby Sanara shareholders stand to receive a total of $35.00 per share. The merger is expected to enhance both companies' market positions in the surgical and regenerative medical fields, …
Synlogic (OTC: SYBX) entered into a definitive merger agreement on July 28, 2026 that will unite it with Caldera in a deal valued at $278 million. Under the terms, Synlogic will become a wholly owned subsidiary of a newly formed parent, while shareholders of …
Tiptree Inc. (NASDAQ: TIPT) has announced a strategic acquisition of Universal Shield Insurance Group for $100 million, which marks a significant step in its expansion within the specialty insurance sector. This acquisition, following a prior divestment of Fortegra valued at $1.65 billion, aligns with …
Westin Acquisition Corp is making significant strides in the healthcare sector with its new merger agreement valued at approximately $650 million. The company has committed to combining operations with First Choice Healthcare Solutions, enhancing its service offerings in functional health and regenerative medicine. This …
Procore Technologies (NYSE: PCOR) is poised to acquire DroneDeploy for an estimated purchase price of around $845 million, significantly enhancing its cloud software capabilities customized for drone technology. This merger aims to integrate DroneDeploy's strong platform, which specializes in automated flight safety checks and …
MiMedx Group (NASDAQ: MDXG) has secured a definitive merger agreement to acquire Sanara MedTech, valued at a total enterprise price of around $350 million. Under the agreement, Sanara’s stakeholders will receive $33.00 per share in cash alongside 0.4735 shares of MiMedx common stock per …
In a significant development for both parties, OCS has obtained an irrevocable commitment from a director of Mitie to support its cash acquisition strategy. This backing elevates the credibility of the deal, encouraging potential investors to view the acquisition in a more favorable light. …
Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) finalized a two‑step merger with Vidya Therapeutics. Each preferred share is designed to become 1,000 common shares upon conversion, a mechanism that reshapes the capital structure of the combined company. Prior to the transaction, Processa’s equity holders possessed roughly …
HeartSciences Inc. (NASDAQ: HSCS) faces mounting challenges as it reports a second-quarter loss of $-0.87 per share for the period ending June 30, 2026, falling short of the $-0.74 expected by analysts. With a market capitalization of about $10 million, the company's stock has …
Inflection Point Acquisition Corp. III has activated a compensation agreement that is contingent on 125,000 Class A ordinary shares held by a service provider prior to finalizing its business combination with Air Water Ventures. The arrangement stipulates that a cash fee to the provider …
Please wait processing your request...